Cited by 123

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer

Schläfli, Anna M., Adams, Olivia, Galván, José A., Gugger, Mathias, Savic, Spasenija, Bubendorf, Lukas, Schmid, Ralph A., Becker, Karl-Friedrich, Tschan, Mario P., Langer, Rupert, Berezowska, Sabina·2016·Oncotarget

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.9647

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. Ohgaki, 2015, World Health Organization Classification of Tumours
  2. Deretic, 2011, Autophagy in immunity and cell-autonomous defense against intracellular microbes, Immunol Rev, 240, 92, 10.1111/j.1600-065X.2010.00995.x · DOI
  3. Glosmann, 2014, A dual role for autophagy in a murine model of lung cancer, Nat Commun, 5, 3056, 10.1038/ncomms4056 · DOI
  4. White, 2014, Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism, Autophagy, 10, 384, 10.4161/auto.27320 · DOI
  5. White, 2011, Role of autophagy in cancer prevention, Cancer Prev Res (Phila), 4, 973, 10.1158/1940-6207.CAPR-10-0387 · DOI
  6. Klionsky, 2014, An overview of autophagy: morphology, mechanism, and regulation, Antioxid Redox Signal, 20, 460, 10.1089/ars.2013.5371 · DOI · Paper page
  7. Yoshimori, 2010, Regulation of membrane biogenesis in autophagy via PI3P dynamics, Semin Cell Dev Biol, 21, 671, 10.1016/j.semcdb.2010.04.002 · DOI
  8. Ohsumi, 2009, Dynamics and diversity in autophagy mechanisms: lessons from yeast, Nat Rev Mol Cell Biol, 10, 458, 10.1038/nrm2708 · DOI
  9. Yoshimori, 2000, LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J, 19, 5720, 10.1093/emboj/19.21.5720 · DOI · Paper page
  10. Penninger, 2015, Autophagy in malignant transformation and cancer progression, EMBO J, 34, 856, 10.15252/embj.201490784 · DOI · Paper page
  11. Devenish, 2012, Receptor protein complexes are in control of autophagy, Autophagy, 8, 1701, 10.4161/auto.21332 · DOI
  12. Kirkin, 2014, Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy, Mol Cell, 53, 167, 10.1016/j.molcel.2013.12.014 · DOI · Paper page
  13. Motohashi, 2012, Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma, Cancer Sci, 103, 760, 10.1111/j.1349-7006.2012.02216.x · DOI
  14. Giatromanolaki, 2011, Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas, Chest, 140, 127, 10.1378/chest.10-1831 · DOI
  15. Koukourakis, 2011, «Autophagic flux» in normal mouse tissues: focus on endogenous LC3A processing, Autophagy, 7, 1371, 10.4161/auto.7.11.16664 · DOI
  16. De Meyer, 2013, Immunohistochemical analysis of macroautophagy: recommendations and limitations, Autophagy, 9, 386, 10.4161/auto.22968 · DOI
  17. Tschan, 2015, Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry, Eur J Histochem, 59, 2481
  18. Hung, 2014, Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma, Br J Cancer, 111, 944, 10.1038/bjc.2014.355 · DOI
  19. Inazawa, 2015, High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer, The American journal of pathology, 185, 2523, 10.1016/j.ajpath.2015.05.008 · DOI
  20. He, 2013, Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer, Onco Targets Ther, 6, 883
  21. Spendlove, 2007, The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease, Endocr Relat Cancer, 14, 73, 10.1677/erc.1.01312 · DOI
  22. Steurer, 2015, Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer, Clin Cancer Res, 21, 3471, 10.1158/1078-0432.CCR-14-0620 · DOI
  23. Zhang, 2015, p62 links autophagy and Nrf2 signaling, Free Radic Biol Med, 88, 199, 10.1016/j.freeradbiomed.2015.06.014 · DOI
  24. Komatsu, 2011, Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells, J Cell Biol, 193, 275, 10.1083/jcb.201102031 · DOI
  25. Wooten, 2007, Signal integration and diversification through the p62 scaffold protein, Trends Biochem Sci, 32, 95, 10.1016/j.tibs.2006.12.002 · DOI
  26. Johnson, 2010, PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation, J Biol Chem, 285, 2077, 10.1074/jbc.M109.065102 · DOI
  27. Johansen, 2010, Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies, J Biol Chem, 285, 5941, 10.1074/jbc.M109.039925 · DOI
  28. Johansen, 2010, p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy, Autophagy, 6, 330, 10.4161/auto.6.3.11226 · DOI
  29. Silver, 2004, Nuclear transport and cancer: from mechanism to intervention, Nat Rev Cancer, 4, 106, 10.1038/nrc1274 · DOI
  30. Christian Wittekind, 2009, International Union Against Cancer (UICC): TNM Classification of Malignant Tumours, 336
  31. Tapia, 2014, Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer, Br J Cancer, 110, 2914, 10.1038/bjc.2014.229 · DOI
  32. Lugli, 2014, A next-generation tissue microarray (ngTMA) protocol for biomarker studies, J Vis Exp, 51893

Cited by

Sorted by citations

See all 123

Metadata

Authors
Schläfli, A. M., Adams, O., Galván, J. A., Gugger, M., Savic, S., Bubendorf, L., Schmid, R. A., Becker, K.-F., Tschan, M. P., Langer, R., & Berezowska, S.
Affiliations
  • Institute of Pathology, University of Bern, Bern, Switzerland
  • Institute of Pathology, Universty Hospital Basel, Basel, Switzerland
  • Division of General Thoracic Surgery, Inselspital University Hospital Bern, Bern, Switzerland
  • Institute of Pathology, Technische Universität München, München, Germany
Venue
Oncotarget
Published
2016-05-26
Volume
7
Issue
26
Pages
39544-39555
ISSN
1949-2553
Cited by
123
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review